AI assistant
Sending…
Xencor Inc — Director's Dealing 2019
Dec 18, 2019
32653_dirs_2019-12-18_517b1dfe-d8e4-4928-86f3-a8f93476c4a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Xencor Inc (XNCR)
CIK: 0001326732
Period of Report: 2019-12-16
Reporting Person: Yang Allen (SVP, Chief Medical Officer)
More from Xencor Inc
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 31
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Feb 25
Annual Report
2026
Feb 25
Regulatory Filings
2026
Feb 25
Director's Dealing
2026
Jan 26